Atai Beckley N.V.

ATAI

Held by 3 specialist biotech funds

High Convergence

3 funds opened new positions. Short interest: 7.3% of float.

Medical - PharmaceuticalsCEO: Srinivas G. RaoIPO: 2021Website ↗

Atai Beckley NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Amstelveen, Netherlands.

Atai Beckley N.V.

Signal Score

Fund Holdings

Position Trend

Short Interest

Catalysts

Position Details

Know which insider moves are real

Insider Signals

Also Held by These Funds

Research Links

Related Research